<ul>
<li>Pomdoctor will change its ADS-to-Class A ordinary share ratio on June 22, 2026.     *      The move equates to a 1-for-18 reverse ADS split; Class A ordinary shares remain unchanged.     *      ADSs are expected to trade on a post-split basis on Nasdaq under ticker POM from the market open.     *      Fractional new ADSs will not be issued; fractional entitlements will be sold for cash distribution. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606170600PR_NEWS_USPR_____CN84610) on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</li>
</ul>

<p>Pomdoctor Ltd. will implement a 1-for-18 reverse ADS split effective June 22, 2026. This adjustment changes the ADS-to-Class A ordinary share ratio while leaving Class A shares unchanged. ADSs are expected to trade on a post-split basis under ticker POM on Nasdaq starting market open. Fractional new ADSs will not be issued; instead, fractional entitlements will be sold for cash distribution.</p>

Pomdoctor to implement 1-for-18 reverse ADS split on June 22